Your browser doesn't support javascript.
loading
Clinical and molecular aspects of breast cancer: Targets and therapies.
Godone, R L N; Leitão, G M; Araújo, N B; Castelletti, C H M; Lima-Filho, J L; Martins, D B G.
Afiliação
  • Godone RLN; Molecular Prospection and Bioinformatics Group, Laboratory Keizo Asami of Immunopathology (LIKA), Federal University of Pernambuco (UFPE), Brazil.
  • Leitão GM; Molecular Prospection and Bioinformatics Group, Laboratory Keizo Asami of Immunopathology (LIKA), Federal University of Pernambuco (UFPE), Brazil; Clinical Hospital of Pernambuco - Professor Romero Marques, Federal University of Pernambuco (UFPE), Brazil.
  • Araújo NB; Molecular Prospection and Bioinformatics Group, Laboratory Keizo Asami of Immunopathology (LIKA), Federal University of Pernambuco (UFPE), Brazil.
  • Castelletti CHM; Molecular Prospection and Bioinformatics Group, Laboratory Keizo Asami of Immunopathology (LIKA), Federal University of Pernambuco (UFPE), Brazil; Agronomic Institute of Pernambuco (IPA), Recife, Pernambuco, Brazil.
  • Lima-Filho JL; Laboratory Keizo Asami of Immunopathology (LIKA), Federal University of Pernambuco (UFPE), Brazil; Department of Biochemistry, Federal University of Pernambuco (UFPE), Brazil.
  • Martins DBG; Molecular Prospection and Bioinformatics Group, Laboratory Keizo Asami of Immunopathology (LIKA), Federal University of Pernambuco (UFPE), Brazil; Department of Biochemistry, Federal University of Pernambuco (UFPE), Brazil. Electronic address: bruneska@prospecmol.org.
Biomed Pharmacother ; 106: 14-34, 2018 Oct.
Article em En | MEDLINE | ID: mdl-29945114

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Biomarcadores Tumorais / Terapia de Alvo Molecular / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Biomed Pharmacother Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Brasil País de publicação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Biomarcadores Tumorais / Terapia de Alvo Molecular / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Biomed Pharmacother Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Brasil País de publicação: França